Trump’s Pharma Tariffs Spare Richest Drugmakers
NegativeScience

Recent developments reveal that President Trump's tariffs on pharmaceuticals are favoring the wealthiest drugmakers, raising concerns about the impact on healthcare costs for everyday Americans. This situation highlights the ongoing debate over drug pricing and access to essential medications, as many fear that the burden of these tariffs will ultimately fall on consumers rather than the companies profiting from them.
— Curated by the World Pulse Now AI Editorial System